References
- Averting HIV and AIDS. Global HIV and AIDS Statistics. AVERT. Averting HIV and AIDS; 2018. p. 1-7. Available from: https://www.avert.org/global-hiv-and-aids-statistics [Accessed: Jan 10; 2022].
- Del Amo J, Polo R, Moreno S, Díaz A, Martínez E, Arribas JR, et al. Incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy: A cohort study. Ann Intern Med. 2020;173(7):536-41. https://doi.org/10.7326/M20-3689 PMid:32589451
- Raftery MJ, Samstag Y. Since January 2020 Elsevier has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company’s Public News and Information. Netherlands: Elsevier; 2020.
- Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LF. The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363-74. https://doi.org/10.1038/s41577-020-0311-8 PMid:32346093
- Therapy A. HHS Public Access. 2019;32(3):277-92. https://doi.org/10.1097/QAD.0000000000001712 [Last accessed on 2022 Jan 10].
- Chen LD, Zhang ZY, Wei XJ, Cai YQ, Yao WZ, Wang MH, et al. Association between cytokine profiles and lung injury in COVID-19 pneumonia. Respir Res. 2020;21(1):201. https://doi.org/10.1186/s12931-020-01465-2 PMid:32727465
- Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med. 2020;217(6):e20200678. https://doi.org/10.1084/jem.20200678
- Cribbs SK, Crothers K, Morris A. Pathogenesis of HIV-related lung disease: Immunity, infection, and inflammation. Physiol Rev. 2020;100(2):603-32. https://doi.org/10.1152/physrev.00039.2018 PMid:31600121
- Agostini C, Semenzato G. Immunologic effects of HIV in the lung. Clin Chest Med. 1996;17(4):633-45. https://doi.org/10.1016/s0272-5231(05)70337-3 PMid:9016369
- Duncan JW, Granger JP, Ryan MJ, Drummond HA. Interleukin-17 reduces βENaC via MAPK signaling in vascular smooth muscle cells. Int J Mol Sci. 2020;21(8):2953. https://doi.org/10.3390/ijms21082953 PMid:32331392
- Sanyaolu A, Okorie C, Marinkovic A, Ayodele O, Abbasi AF, Prakash S, et al. Navigating the diagnostics of COVID-19. SN Compr Clin Med. 2020;2(9):1393-400. https://doi.org/10.1007/s42399-020-00408-8 PMid:32838176
- Kanwugu ON, Adadi P. HIV/SARS-CoV-2 coinfection: A global perspective. J Med Virol. 2021;93(2):726-32. https://doi.org/10.1002/jmv.26321 PMid:32692406
- Eisinger RW, Lerner AM, Fauci AS. HIV/AIDS in the era of COVID-19: A juxtaposition of two pandemics. J Infect Dis. 2021;224:1449-51. https://doi.org/10.1093/infdis/jiab114
- Blanco JL, Ambrosioni J, Garcia F, Martínez E, Soriano A, Mallolas J, et al. COVID-19 in patients with HIV: Clinical case series. Lancet HIV. 2020;7(5):e314-6. https://doi.org/10.1016/S2352-3018(20)30111-9 PMid:32304642
- Wang M, Luo L, Bu H, Xia H. One case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a low CD4+ T-cell count. Int J Infect Dis. 2020;96:148-50. https://doi.org/10.1016/j.ijid.2020.04.060 PMid:32335339
- Zhang JC, Yu XH, Ding XH, Ma HY, Cai XQ, Kang SC, et al. New HIV diagnoses in patients with COVID-19: Two case reports and a brief literature review. BMC Infect Dis. 2020;20(1):771. https://doi.org/10.1186/s12879-020-05480-y PMid:33076830
- Pata RK, Ahmady A, Kiani R. Human immunodeficiency virus: A dark cloud with silver lining during the COVID-19 pandemic. Cureus. 2020;12(7):e9302. https://doi.org/10.7759/cureus.9302 PMid:32832299
- Suwanwongse K, Shabarek N. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York City. J Med Virol. 2020;92(11):2387-9. https://doi.org/10.1002/jmv.26077 PMid:32462663
- Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. J Med Virol. 2020;92(11):2288-90. https://doi.org/10.1002/jmv.25955 PMid:32347975
- Shalev N, Scherer M, LaSota ED, Antoniou P, Yin MT, Zucker J, et al. Clinical characteristics and outcomes in people living with human immunodeficiency virus hospitalized for coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2294-7. https://doi.org/10.1093/cid/ciaa635 PMid:32472138
- Karmen-Tuohy S, Carlucci PM, Zervou FN, Zacharioudakis IM, Rebick G, Klein E, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2020;85(1):6-10. https://doi.org/10.1097/QAI.0000000000002423 PMid:32568770
- Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620-9. https://doi.org/10.1172/JCI137244 PMid:32217835
- Mascolo S, Romanelli A, Carleo MA, Esposito V. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better. J Med Virol. 2020;92(10):1777-8. https://doi.org/10.1002/jmv.25881 PMid:32293709
- Hong LZ, Shou ZX, Zheng DM, Jin X. The most important biomarker associated with coagulation and inflammation among COVID-19 patients. Mol Cell Biochem. 2021;476:2877-85. https://doi.org/10.1007/s11010-021-04122-4 PMid:33742367
- Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 - a systematic review. Life Sci. 2020;254:117788. https://doi.org/10.1016/j.lfs.2020.117788 PMid:32475810
- Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Milit Med Res. 2020;7:11. https://doi.org/10.1186/s40779-020-00240-0
- Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: A systematic review and meta-analysis. Sci Rep. 2021;11(1):6283. https://doi.org/10.1038/s41598-021-85359-3 PMid:33737527
- Malik P, Patel U, Mehta D, Patel N, Kelkar R, Akrmah M, et al. Biomarkers and outcomes of COVID-19 hospitalisations: Systematic review and meta-analysis. BMJ Evid Based Med. 2020;26:107-8. https://doi.org/10.1136/bmjebm-2020-111536 PMid:32934000
- Potempa LA, Rajab IM, Hart PC, Bordon J, Fernandez-Botran R. Insights into the use of C-reactive protein as a diagnostic index of disease severity in COVID-19 infections. Am J Trop Med Hyg. 2020;103(2):561-3. https://doi.org/10.4269/ajtmh.20-0473 PMid:32588812
- Ahnach M, Zbiri S, Nejjari S, Ousti F, Elkettani C. C-reactive protein as an early predictor of COVID-19 severity. J Med Biochem. 2020;39(4):500-7. https://doi.org/10.5937/jomb0-27554 PMid:33312067
- Wang L. C-reactive protein levels in the early stage of COVID-19. Med Mal Infect. 2020;50(4):332-4. https://doi.org/10.1016/j.medmal.2020.03.007 PMid:32243911
- Sharifpour M, Rangaraju S, Liu M, Alabyad D, Nahab FB, Creel-Bulos CM, et al. C-reactive protein as a prognostic indicator in hospitalized patients with COVID-19. PLoS One. 2020;15(11):e0242400. https://doi.org/10.1371/journal.pone.0242400 PMid:33216774
- Kartawidjaja J. Covariance structure analysis of health-related indicators in home-bound elderly people focusing on subjective sense of health title. Orphanet J Rare Dis. 2020;21(1):1-9.
- Vargas-Vargas M, Cortés-Rojo C. Letter to the editor Ferritin levels and COVID-19. Ther Adv Vaccines. 2020;9(5):2019-20.
- Arora P. Correlation between serum ferritin and glycated hemoglobin level in patients of type 2 diabetes mellitus. Int J Cur Res Rev. 2017;9(6):30-33.
- Lino K, Guimarães GM, Alves LS, Oliveira AC, Faustino R, Fernandes CS, et al. Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality. Braz J Infect Dis. 2021;25(2):101569. https://doi.org/10.1016/j.bjid.2021.101569 PMid:33736948
- Dahan S, Segal G, Itai K, HellouT, Tietel M, Bryk G, et al. Ferritin as a marker of severity in COVID-19 patients: A fatal correlation. Isr Med Assoc J. 2020;22(8):494-500. PMid:33236582
- Carubbi F, Salvati L, Alunno A, Maggi F, Borghi E, Mariani R, et al. Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: Data from two Italian COVID-19 units. Sci Rep. 2021;11(1):4863. https://doi.org/10.1038/s41598-021-83831-8 PMid:33649408
- Syed Khalid M, Aljohani MM, Alomrani NA, Oyoun AA, Alzahrani O, Ahmad MA, et al. COVID-19 and immune function - “a significant” zinc. Oriental J Chem. 2020;36(6):1026-36. https://doi.org/10.13005/ojc/360604
- Bartziokas K, Kostikas K. Lactate dehydrogenase, COVID-19 and mortality. Med Clin (Barc). 2021;156(1):37-43. https://doi.org/10.1016/j.medcli.2020.07.043 PMid:33168150
- Henry BM, Aggarwal G, Wong J, Benoit S, Vikse J, Plebani M, et al. Since January 2020 Elsevier has Created a COVID-19 Resource Centre with Free Information in English and Mandarin on the Novel Coronavirus COVID- 19. The COVID-19 Resource Centre is Hosted on Elsevier Connect, the Company’s Public News and Information. Netherlands: Elsevier; 2020.
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 PMid:31986264
- Kang HE, Park DW. Lactate as a biomarker for sepsis prognosis? Infect Chemother. 2016;48(3):252-53. https://doi.org/10.3947/ic.2016.48.3.252 PMid:27704736
- Martha JW, Wibowo A, Pranata R. Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: A systematic review and meta-analysis. Postgrad Med J. 2022;98(1160):422-7. https://doi.org/10.1136/postgradmedj-2020-139542
- Demelo-Rodriguez P, Cervilla-Munoz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Macías M, Toledo-Samaniego N, et al. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res. 2020;192:23-26. https://doi.org/10.1016/j.thromres.2020.05.018 PMid:32405101
- Eljilany I, Elzouki AN. D-dimer, fibrinogen, and IL-6 in COVID-19 patients with suspected venous thromboembolism: A narrative review. Vasc Health Risk Manag. 2020;16:455-62. https://doi.org/10.2147/VHRM.S280962 PMid:33223833
- Porfidia A, Pola R. Venous thromboembolism in COVID-19 patients. J Thromb Haemost. 2020;18(6):1516-7. https://doi.org/10.1111/jth.14842 PMid:32294289
- Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care. 2020;8:49. https://doi.org/10.1186/s40560-020-00466-z PMid:32665858
- Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18(6):1324-9. https://doi.org/10.1111/jth.14859 PMid:32306492
- He X, Yao F, Chen J, Wang Y, Fang X, Lin X, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Sci Rep. 2021;11(1):1830. https://doi.org/10.1038/s41598-021-81300-w PMid:33469072
- Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERSCoV and lessons from the past. J Clin Virol. 2020;127:104362. https://doi.org/10.1016/j.jcv.2020.104362 PMid:32305883
- Palmer WJ. Elevated D-Dimer Values Can Help Select Better COVID-19 Patients for CT Pulmonary Angiography 2020. Available from: https://www.diagnosticimaging.com/view/elevated-d-dimer-values-can-help-select-better-covid-19-patients-for-ct-pulmonary-angiography [Last accessed on 2022 Jan 10].
- Vatansever HS, Becer E. Relationship between IL-6 and COVID-19: To be considered during treatment. Future Virol. 2020;15:817-22. https://doi.org/10.2217/fvl-2020-0168
- Sabaka P, Koščálová A, Straka I, Hodosy J, Lipták R, Kmotorková B, et al. Role of interleukin 6 as a predictive factor for a severe course of Covid-19: Retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak. BMC Infect Dis. 2021;21(1):308. https://doi.org/10.1186/s12879-021-05945-8 PMid:33781216